Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 14 tags : Cardio save search
PLx Pharma, Inc. Issues Statement on Recent USPSTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease; PLx’s VAZALORE Specifically Indicated for Secondary Prevention
Published: 2021-10-14 (Crawled : 15:00) - ir.plxpharma.com
PLXP | $0.087 -4.6% 50M
|
Health Technology
|
| O: 0.12%
H: 1.04%
C: -16.83%
disease cardiovascular therapy cardio
MemorialCare Earns National Recognition for Efforts to Improve Cardiovascular, Diabetes and Stroke Treatment
Published: 2021-10-14 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.19%
H: 0.0%
C: 0.0%
diabetes treatment stroke cardiovascular cardio
PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease
Published: 2021-10-14 (Crawled : 19:00) - biospace.com/
PLXP | $0.087 -4.6% 50M
|
Health Technology
|
| O: 0.12%
H: 1.04%
C: -16.83%
disease cardiovascular therapy cardio
PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease; PLx’s VAZALORE Specifically Indicated for Secondary Prevention
Published: 2021-10-14 (Crawled : 18:00) - globenewswire.com
PLXP | $0.087 -4.6% 50M
|
Health Technology
|
| O: 0.12%
H: 1.04%
C: -16.83%
disease cardiovascular therapy cardio
Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock Tuesday, October 19th @ 8:00 am Eastern Time
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
WINT | $5.085 -10.53% -11.77% 51K
|
Health Technology
|
| O: 1.32%
H: 1.74%
C: -0.87%
treatment heart cardio
Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock
Published: 2021-10-14 (Crawled : 12:00) - globenewswire.com
WINT | $5.085 -10.53% -11.77% 51K
|
Health Technology
|
| O: 1.32%
H: 1.74%
C: -0.87%
treatment heart cardio
First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery
Published: 2021-10-14 (Crawled : 11:00) - prnewswire.com
CTSO | $0.821 -6.6% -7.06% 180K
|
Health Technology
|
| O: 0.33%
H: 0.49%
C: -2.6%
drug iot cardio trial enroll
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.